787 related articles for article (PubMed ID: 16752713)
1. Implantable left ventricular assist devices: new hope for patients with end-stage heart failure.
Milano CA; Lodge AJ; Blue LJ; Smith PK; Felker GM; Hernandez AF; Rosenberg PB; Rogers JG
N C Med J; 2006; 67(2):110-5. PubMed ID: 16752713
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
[TBL] [Abstract][Full Text] [Related]
4. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
[TBL] [Abstract][Full Text] [Related]
5. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era.
Miller LW; Nelson KE; Bostic RR; Tong K; Slaughter MS; Long JW
J Heart Lung Transplant; 2006 Jul; 25(7):778-84. PubMed ID: 16818120
[TBL] [Abstract][Full Text] [Related]
6. Permanent mechanical circulatory support in patients of advanced age.
Jurmann MJ; Weng Y; Drews T; Pasic M; Hennig E; Hetzer R
Eur J Cardiothorac Surg; 2004 Apr; 25(4):610-8. PubMed ID: 15037280
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
[TBL] [Abstract][Full Text] [Related]
8. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
[TBL] [Abstract][Full Text] [Related]
9. Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation.
Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Zuckermann AO; Wieselthaler GM
J Heart Lung Transplant; 2009 Apr; 28(4):367-72. PubMed ID: 19332264
[TBL] [Abstract][Full Text] [Related]
10. Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005.
Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Miller LW; Deng M; Naka Y; Mancini D
Circ Heart Fail; 2009 Jan; 2(1):3-10. PubMed ID: 19808309
[TBL] [Abstract][Full Text] [Related]
11. Assessment of recurrent heart failure associated with left ventricular assist device dysfunction.
Jaski BE; Miller DA; Hoagland PM; Gordon JB; Chillcott SR; Stahovich MJ; Adamson RM; Baradarian S; Dembitsky WP
J Heart Lung Transplant; 2005 Dec; 24(12):2060-7. PubMed ID: 16364850
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.
Kühne M; Sakumura M; Reich SS; Sarrazin JF; Wells D; Chalfoun N; Crawford T; Boonyapisit W; Horwood L; Chugh A; Good E; Jongnarangsin K; Bogun F; Oral H; Morady F; Pagani F; Pelosi F
Am J Cardiol; 2010 Feb; 105(3):378-82. PubMed ID: 20102952
[TBL] [Abstract][Full Text] [Related]
13. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.
Dang NC; Topkara VK; Mercando M; Kay J; Kruger KH; Aboodi MS; Oz MC; Naka Y
J Heart Lung Transplant; 2006 Jan; 25(1):1-6. PubMed ID: 16399523
[TBL] [Abstract][Full Text] [Related]
14. Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure.
Jurmann MJ; Siniawski H; Erb M; Drews T; Hetzer R
Ann Thorac Surg; 2004 May; 77(5):1642-7. PubMed ID: 15111158
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular assist devices as destination therapy: a new look at survival.
Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy.
Topilsky Y; Pereira NL; Shah DK; Boilson B; Schirger JA; Kushwaha SS; Joyce LD; Park SJ
Circ Heart Fail; 2011 May; 4(3):266-75. PubMed ID: 21303989
[TBL] [Abstract][Full Text] [Related]
17. Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices.
Zimpfer D; Zrunek P; Sandner S; Schima H; Grimm M; Zuckermann A; Wolner E; Wieselthaler G
Eur J Cardiothorac Surg; 2007 Apr; 31(4):698-702. PubMed ID: 17289396
[TBL] [Abstract][Full Text] [Related]
18. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices.
Argenziano M; Catanese KA; Moazami N; Gardocki MT; Weinberg AD; Clavenna MW; Rose EA; Scully BE; Levin HR; Oz MC
J Heart Lung Transplant; 1997 Aug; 16(8):822-31. PubMed ID: 9286774
[TBL] [Abstract][Full Text] [Related]
19. Effect of diabetes on short- and long-term outcomes after left ventricular assist device implantation.
Topkara VK; Dang NC; Martens TP; Cheema FH; Liu JF; Liang LM; Cheema AF; Barili F; Oz MC; Naka Y
J Heart Lung Transplant; 2005 Dec; 24(12):2048-53. PubMed ID: 16364848
[TBL] [Abstract][Full Text] [Related]
20. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
